Division of Structural Biology, The Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.
Nat Commun. 2023 Nov 22;14(1):7627. doi: 10.1038/s41467-023-43434-5.
Human metapneumovirus (HMPV) is a major cause of respiratory illness in young children. The HMPV polymerase (L) binds an obligate cofactor, the phosphoprotein (P). During replication and transcription, the L/P complex traverses the viral RNA genome, which is encapsidated within nucleoproteins (N). An essential interaction between N and a C-terminal region of P tethers the L/P polymerase to the template. This N-P interaction is also involved in the formation of cytoplasmic viral factories in infected cells, called inclusion bodies. To define how the polymerase component P recognizes N-encapsidated RNA (N-RNA) we employed cryogenic electron microscopy (cryo-EM) and molecular dynamics simulations, coupled to activity assays and imaging of inclusion bodies in cells. We report a 2.9 Å resolution structure of a triple-complex between multimeric N, bound to both RNA and the C-terminal region of P. Furthermore, we also present cryo-EM structures of assembled N in different oligomeric states, highlighting the plasticity of N. Combined with our functional assays, these structural data delineate in molecular detail how P attaches to N-RNA whilst retaining substantial conformational dynamics. Moreover, the N-RNA-P triple complex structure provides a molecular blueprint for the design of therapeutics to potentially disrupt the attachment of L/P to its template.
人偏肺病毒(HMPV)是导致幼儿呼吸道疾病的主要原因。HMPV 聚合酶(L)结合必需的辅助因子,磷蛋白(P)。在复制和转录过程中,L/P 复合物穿过病毒 RNA 基因组,该基因组被核蛋白(N)包裹。N 和 P 的 C 末端区域之间的关键相互作用将 L/P 聚合酶固定在模板上。这种 N-P 相互作用还参与感染细胞中细胞质病毒工厂(称为包涵体)的形成。为了确定聚合酶成分 P 如何识别 N 包裹的 RNA(N-RNA),我们采用低温电子显微镜(cryo-EM)和分子动力学模拟,结合活性测定和细胞内包涵体成像。我们报告了一个三重复合物的 2.9Å 分辨率结构,该复合物由多聚体 N 组成,与 RNA 和 P 的 C 末端区域结合。此外,我们还展示了不同寡聚状态下组装的 N 的 cryo-EM 结构,突出了 N 的可塑性。结合我们的功能测定,这些结构数据详细描述了 P 如何附着在 N-RNA 上,同时保留了大量的构象动力学。此外,N-RNA-P 三重复合物结构为设计潜在破坏 L/P 与其模板结合的治疗药物提供了分子蓝图。